Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

1. Cequier, Á.
2. Arrarte, V.
3. Campuzano, R.
4. Castro, A.
5. Cordero, A.
6. Fernández Olmo, M.R.
7. García-Moll, X.
8. Gómez Doblas, J.J.
9. López de Sá, E.
10. Núñez, J.
11. Pintó Sala, X.
12. Cosín, J.
13. González Juanatey, J.R.
14. Zamorano, J.L.
15. Anguita, M.
16. Rodríguez Padial, L.
17. López Sendón, J.L.